Sabra Health Care REIT (SBRA) Stock Fundamentals, Analysis & Risk Signals

Health score, price, valuation, risk signals, and key metrics at a glance.

Sabra Health Care REIT

NasdaqGS•Real Estate•REIT - Healthcare Facilities

$20.09-0.18(-0.01%)Pre-market

Market Cap

$5.08B

P/E

77.7x

P/S

5.9x

P/B

1.8x

Sabra Health Care REIT, Inc. operates as a self-administered, self-managed real estate investment trust that, through its subsidiaries, owns and invests in real estate serving the healthcare industry throughout the United States and Canada. Sabra Health Care REIT, Inc. is incorporated on May 10th, 2010 and is based in Tustin, United States.

How this company scores

AverageMetricSide Score: 46/100

Strongest: Growth (14/25); weakest: Cash & Earnings Quality (9/25).

Profitability10/25

Growth14/25

Balance Sheet & Red Flags13/25

Cash & Earnings Quality9/25

Strengths

Growing revenueStrong marginsConsistent growth

Valuation vs. 5-year range

Today's multiple positioned against its own trailing range — a visual premium/discount check.

P/E · 77.7x5y range 24.1x – 239.9x

Currently above its 14-quarter median.

P/S · 5.9x5y range 4.2x – 6.4x

Currently near its 20-quarter median.

P/B · 1.8x5y range 0.9x – 1.8x

Watch items

Data-driven signals worth keeping an eye on across the last 8 quarters

High Risk

Margin Pressure

Watch

Operating margins declined 14.7% — watch for continued compression, which may signal competitive or cost pressure.

Earnings Quality

Watch

FCF/Net Income has dropped below 0.7x in 4 quarters — monitor for earnings quality deterioration.

Price & Volume

Market Cap $5.08B

Metrics at a Glance

as of June 2026

Revenue & Profit

Revenue, EBITDA, operating income, net income, EPS, and shares

TTM Revenue: $859.56M
Q. Revenue: $235.87M
TTM EBITDA: $689.42M
TTM Op. Income: $479.99M
Q. Op. Income: $57.34M
TTM Net Income: $65.44M
Q. Net Income: $-25.20M
EPS: $-0.1
Shares Out.: $252.27M

$859.56M in TTM revenue grew 17.3% YoY, reaching $235.87M last quarter. TTM EBITDA of $689.42M and TTM operating income of $479.99M show growth is flowing through to the bottom line. TTM net income of $65.44M means revenue is converting into profit. Across the last 8 quarters, TTM revenue has risen for 7 consecutive quarters — an improving trend.

Margins

Gross, EBITDA, operating, and net margin trends

EBITDA Margin: 48.2%
Op. Margin: 24.3%
Net Margin: -10.7%

Op. margin of 24.3% is down 35.9% YoY — costs are rising relative to revenue. Net margin at -10.7% Over the past year, operating margin is down 60% — a weakening trend.

Price Ratios

P/E, P/S, P/B, EV/EBITDA, FCF yield, and earnings yield

P/E Ratio: 77.7x
P/S Ratio: 5.9x
P/B Ratio: 1.8x

At 77.7x P/E, the stock trades above typical market levels — the market expects above-average growth. P/S of 5.9x and P/B of 1.8x provide additional context. Use the growth and margin sections to judge whether the multiple is justified. Across the last 8 quarters, P/E has risen for 4 consecutive quarters — a weakening trend.

Assets & Liabilities

Total assets, cash, debt, book value, and leverage

Total Assets: $5.51B
Cash: $231.58M
Long-Term Debt: $2.63B
Book Value: $2.75B
D/E Ratio: 1.0
Debt/EBITDA: 23.1

With $5.51B in assets and $2.63B in long-term debt, D/E is 1.0and book value is $2.75B — a conservative capital structure with a cushion to weather downturns. Over the past year, debt/equity is up 4% — an improving trend.

Cash Flow

Operating cash flow, free cash flow, FCF margin, and earnings quality

Op. Cash Flow: $85.82M
TTM Free Cash Flow: $-312.75M
FCF Margin: -36.4%
FCF / Net Income: -4.8

TTM FCF of $-312.75M on $85.82M in operating cash flow. The FCF / Net Income ratio of -4.8x means the business consumes cash — it is not yet self-funding. Across the last 8 quarters, free cash flow has fallen for 5 consecutive quarters — a weakening trend.